RxDoctor Payments Data
★ My doctorsLook up a doctor →

Kathleen Ozsvath, MD

Vascular Surgery · Albany, NYNPI 1700867629

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $133,450 of the $183,484 with a category attached, or 72.7%. Medtronic accounts for 74.5% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $53,225, 7.0 times the $7,559 reported in 2019. Among vascular surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$183,484in general payments, 2019–2025

Across 348 payments — averaging $527.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$137K
  • Boston Scientific$19K
  • Penumbra, Inc.$11K
  • Convatec Inc.$10K
  • Servier Affaires Medicales$2K
  • Terumo Medical Corporation$2K
  • plus $3K from 17 others
$9,650in research payments, 2019–2025

Across 3 payments — averaging $3216.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$10K

What the payments were for

  • Consulting fees$25,56314%
  • Speaking & faculty fees$133,45073%
  • Travel & lodging$11,5086%
  • Food & beverage$12,9647%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)242$136,746
Boston Scientific26$18,764
Penumbra, Inc.7$10,866
Convatec Inc.7$9,676
Servier Affaires Medicales1$2,150
Terumo Medical Corporation17$2,004
Lemaitre Vascular, Inc.10$851
Silk Road Medical, Inc.4$848
W. L. Gore & Associates, Inc.3$428
Hydrofera LLC2$276
Tactile Systems Technology Inc6$239
Advanced Oxygen Therapy Inc.1$99
Inari Medical, Inc.1$90
Johnson & Johnson4$86
Cook Medical LLC3$69
Bard Peripheral Vascular, Inc.3$65
Abbott3$60
Abiomed2$55
E.r. Squibb & Sons, L.L.C.2$31
Organogenesis Inc.1$27
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)1$21
AstraZeneca1$19
Edwards Lifesciences1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$183,484 in reported general payments places this provider in the 95th percentile of 405 vascular surgery providers in New York.

See all vascular surgery providers in New York →

Medicare billing

Part B allowed, 2024
$271,600
Medicare patients
702
Services billed
1,595

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate20$163

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Albany

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →